Newormics selected for the NIH I-Corps

Newormics was selected for the NIH I-Corps April-June 2019 cohort. Over the course of the I-Corps program, the team had conversations with over 100 stakeholders in the field. This helped the company gather vital market research to understand the needs and pain points of potential customers, and improve Newormics product lines  The program finale was Read more about Newormics selected for the NIH I-Corps[…]